Home
Balyasny Asset Management reported a 7.4% stake in Contineum Therapeutics CTNM · 2,417,723 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 7.4%
- Last report
- 7.6% · filed 26/02/17
- Shares held
- 2,417,723 sh
- Class
- Class A Common Stock, par value $0.001 per share
- Event date
- 26/03/31
- Filed
- 26/05/15
7.4% stake · −0.2pp from the last report
- Stake
- 7.4%
- Last report
- 7.6%
- Since last report
- −0.2pp
Contineum Therapeutics trades, last 26 weeks
What else happened in Contineum Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Balyasny Asset Management's other 5% stake reports
- Balyasny Asset Management
5% stakeBeyond Air
5% stakeBeyond Air
XAIR
5.3% stake
763,266 sh
5.3% stake
Filed 08/14
- Balyasny Asset Management
5% stakeSagimet Biosciences
5% stakeSagimet Biosciences
SGMT
5.93% stake
3,626,113 sh
5.93% stake
Filed 08/14
- Balyasny Asset Management
5% stakeRezolute
5% stakeRezolute
RZLT
4.84% stake
4,662,039 sh
4.84% stake
Filed 08/14
- Balyasny Asset Management
5% stakeRallybio
5% stakeRallybio
RLYB
0% stake
0 sh
0% stake
Filed 08/14
- Balyasny Asset Management
5% stakeResearch Alliance Corp III
5% stakeResearch Alliance Corp III
RACC
6.43% stake
500,000 sh
6.43% stake
Filed 08/14
